September 27, 2022
Urb-it AB operates in the logistics sector and provides parcel delivery services. Customers can be found in a number of sectors, with a main focus on the e-commerce market. The business is operated through several subsidiaries in France and Great Britain. The share issue was directed to a pre-committed circle of existing investors, including Fjärde AP-fonden, Handelsbanken Fonder and Skandia.
» Read moreSeptember 13, 2022
InCoax specializes in the innovation of reusing existing in-building infrastructure for fiber access, providing Multi-Gigabit broadband to the world's leading telecom and broadband service operators. InCoax has successfully established a partnership with Google Fiber and completed field tests and received an initial order from an American Tier-1 operator, clearly demonstrating the company’s potential. Target markets include US and Europe, markets with growing fiber infrastructure, low household connectivity and high labour costs, implying a huge potential for InCoax’s cost-efficient Fiber Access Extension solutions.
» Read moreAugust 11, 2022
Precise Biometrics AB is a global identification software provider, offering products with a range of application for identification in a convenient and secure way. Precise offers products with various applications that enable individuals to identify themselves by using biometrics. Precise operates through two product areas: Digital Identity, which enable identification for physical access through biometrics (e.g., fingerprints, heart rate, facial and iris recognition) and Algo Software systems which is a leading embedded software for fingerprint recognition meeting various needs in smartphones, smart-lock doorhandles, and various applications in cars.
» Read moreJuly 25, 2022
Rebelle operates the European online marketplace Rebelle.com for selling and buying luxury second hand fashion items and accessories. Rebelle is offering products from the world’s most sought-after fashion brands, such as Louis Vuitton, Chanel, Gucci, Hermès and Prada while increasing customers awareness of sustainability and circularity within the fashion industry.
» Read moreJuly 18, 2022
Movs Technology Group is today the market leader in electric mopeds, and the leading dealer of electric bikes in Sweden. The company has developed several market-leading brands in Sweden: Baotian, Vässla, Drax, Niu and Lifebike. The Mobility-as-a-Service service MOVS is a subscription service for long-term rental of bikes, as well as light electric vehicles such as electric bikes and electric mopeds.
» Read moreJuly 4, 2022
IRRAS is a global medical care company focused on delivering innovative medical solutions to improve the lives of critically ill patients. IRRAS designs, develops, and commercializes neurocritical care products that transform patient outcomes and decrease the overall cost of care by addressing complications associated with current treatment methodologies.
» Read moreMay 25, 2022
ZignSec AB (publ) is a RegTech company, providing an integrated end-to-end KYC, KYB compliance platform, facilitating seamless customer onboarding and monitoring, so clients can confidently expand operations internationally while remaining compliant. Currently ZignSec has more than 500 customers spread across a range of industries where identification is essential, with the greatest concentration in financial services and other regulated activities.
» Read moreApril 8, 2022
Moberg Pharma AB is a Swedish pharmaceutical company focused on commercializing proprietary innovations based on drug delivery of proven compounds. The Company’s main asset, MOB-015, is a novel topical treatment for onychomycosis. Data from phase 3 clinical trials in more than 800 patients for MOB-015 indicate that the product has the potential to become the future market leader in onychomycosis. Moberg Pharma has agreements with commercial partners in place in Europe and Japan, among others, and the Company's goal is to receive its first market approval and launch MOB-015 in 2023.
» Read moreApril 6, 2022
ExpreS2ion Biotech is a biotechnology company that develops vaccines based on complex proteins targeting infectious diseases and cancer. The company develops a pipeline of preventive and therapeutic vaccine products while generating revenue by outlicensing the company’s ExpreS2 platform. The lead candidate targeting COVID-19 is outlicensed to Bavarian Nordic, with positive phase II data announced in February 2022 and phase III expected to be initiated during H1 2022.
» Read moreMarch 15, 2022
S2Medical AB is a company founded in 2013 based in Linköping that develops and sells wound healing products with a focus on burns and chronic wounds. The company aims to offer a holistic concept in wound healing with products in debridement (cleaning of wounds), granulation (construction of blood vessel-rich tissue) and re-epithelialization (outer tissue growth).
» Read moreFebruary 25, 2022
Rebelle operates the European online marketplace Rebelle.com for selling and buying luxury second hand fashion items and accessories. Rebelle is offering products from the world’s most sought after fashion brands, such as Louis Vuitton, Chanel, Gucci, Hermès and Prada while increasing customers awareness of sustainability and circularity within the fashion industry. Rebelle offers more than 200,000 products to, and listed by, customers throughout Europe with focus on the EU.
» Read moreDecember 21, 2021
Cyxone is a Swedish clinical stage medicine platform company focused on developing and advancing novel solutions for patients suffering from severe autoimmune diseases such as rheumatoid arthritis (RA) and multiple sclerosis (MS). “The proceeds from the Rights Issue will enable us to implement the next important steps in the development of Cyxone’s new treatment for rheumatoid arthritis (RA). We have a solid and well-structured plan for delivering value creation to our shareholders and to patients world-wide, and our experienced team are now looking forward to take the Company to the next level,” comments Tara Heitner, CEO, Cyxone.
» Read moreDecember 17, 2021
Idogen is a Swedish biotechnology company that develops tolerogenic cell therapies with the aim of treating unwanted activation of the immune system. The Company conducts three development areas with a focus on treating patients with unwanted activation of the immune system. For the most advanced candidate, IDO 8, intended for patients with severe hemophilia and with antibodies against their treatment, the company’s intention is to submit an application for approval to start a clinical phase I/IIa study in December 2021.
» Read moreNovember 30, 2021
Precise Biometrics is a global identification software provider, offering products with a range of application for identification in a convenient and secure way. Precise offers products with various applications that enable individuals to identify themselves by using biometrics. Precise intends to use the net proceeds from the directed issue to finance part of the company’s acquisition of EastCoast Solutions.
» Read moreOctober 29, 2021
SenzaGen aims to be a leader in non-animal toxicology testing driving the transition from animal testing to methods better suited to reflect human biology. The company has a growth strategy which involve continued commercialization of the in house developed GARD® test platform, expansion of the test portfolio with a broader range of tests and pursuing acquisition opportunities of profitable and growing companies with complementary offerings
» Read moreSeptember 7, 2021
Vator Securities acts as Financial Adviser in connection with the transaction raising SEK 67,6 million. Sprint Bioscience develops small-molecule first-in-class drug projects with a focus on oncology. Using fragment-based drug discovery, the company develops drug projects in a time- and resource-efficient way. These are then out-licensed to global drug companies during the preclinical phase.
» Read more